Drug Type Fab fragment |
Synonyms 25.3 monoclonal antibody, Anti-CD11a monoclonal antibody 25.3, Anti-LFA-1 monoclonal antibody + [1] |
Target |
Mechanism CD11a antagonists(Leukocyte adhesion glycoprotein LFA-1 alpha antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date FR (01 Jan 1997), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Odulimomab | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Graft vs Host Disease | FR | - | 01 Jan 1997 |
Renal transplant rejection | FR | - | 01 Jan 1997 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Delayed Graft Function | Phase 3 | US | - | |
Delayed Graft Function | Phase 3 | EU | - | |
Delayed Graft Function | Phase 3 | CA | - |